Dawn Adams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dawn Adams has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Ejay Nsugbe
Nsugbe Research Labs, Swindon SN1 3LG, UK
4 shared publications - Oluwarotimi Williams Samuel
University of Derby
2 shared publications Aisling Ann O’KAne
School of Computer Science, University of Bristol, Bristol, UK
1 shared publicationAnne Bonhoure
Montreal Clinical Research Institute, Montreal, QC, Canada
1 shared publicationCameron Keighron
University of Galway, Galway, Ireland
1 shared publication- Carol J. Levy
Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA
1 shared publication
Latest Publications
- Open Access
- 22 August 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (10) , e70420
Impact of diabetes mellitus on the menopausal experience: A scoping review
Aims: To identify, appraise and synthesise the current evidence relating to symptoms, experiences, management and impact of menopause on QoL among women with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) and to identify evidence gaps. Methods: We conducted a scoping review guided by Arksey and O'Mally's framework by searching CINAHL, MEDLINE, EMBASE, PsychINFO and PubMed using an iterative approach to pre‐specified eligibility criteria which were reviewed with increasing familiarity with the literature. Studies focusing on peri‐menopausal and menopausal people assigned female at birth with a diagnosis of T1DM or T2DM were included. Results: In total, 16,681 records were identified from which 77 papers were subjected to full review, with 22 eligible. Research focus and methodology varied: 16 observational studies, 2 expert consensus reviews, 2 interventional studies, 1 patient and public involvement paper and 1 qualitative grounded theory paper. PRISMA‐ScR guidelines were followed for transparency of reporting. Findings indicate women with diabetes experience menopausal symptoms similar to those of women without diabetes; however, they may be at risk of increased severity of symptoms, HRT use was linked to lower HbA1c levels but is largely overlooked, limited research has been undertaken exploring women's experiences and awareness of support during the menopause; existing research evidence suggests they are ill‐informed and lacking effective evidence based support. There is a particular dearth of evidence relating to women with T1DM. Conclusions: This review provides evidence that menopause has a negative influence upon quality of life for many women with diabetes. The impacts span managing diabetes and menopausal symptoms and seeking and receiving support. A hypothesised bidirectional relationship between diabetes and menopause may exist: whereby progression of one may be influenced by the other also resulting in a lower quality of life. While high‐level evidence on this complex inter‐relationship remains limited, particularly in T1DM populations, it suggests significant unmet need for those experiencing diabetes and menopause together.
- 22 August 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (10) , e70420
Open AccessImpact of diabetes mellitus on the menopausal experience: A scoping review
Aims: To identify, appraise and synthesise the current evidence relating to symptoms, experiences, management and impact of menopause on QoL among women with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) and to identify evidence gaps. Methods: We conducted a scoping review guided by Arksey and O'Mally's framework by searching CINAHL, MEDLINE, EMBASE, PsychINFO and PubMed using an iterative approach to pre‐specified eligibility criteria which were reviewed with increasing familiarity with the literature. Studies focusing on peri‐menopausal and menopausal people assigned female at birth with a diagnosis of T1DM or T2DM were included. Results: In total, 16,681 records were identified from which 77 papers were subjected to full review, with 22 eligible. Research focus and methodology varied: 16 observational studies, 2 expert consensus reviews, 2 interventional studies, 1 patient and public involvement paper and 1 qualitative grounded theory paper. PRISMA‐ScR guidelines were followed for transparency of reporting. Findings indicate women with diabetes experience menopausal symptoms similar to those of women without diabetes; however, they may be at risk of increased severity of symptoms, HRT use was linked to lower HbA1c levels but is largely overlooked, limited research has been undertaken exploring women's experiences and awareness of support during the menopause; existing research evidence suggests they are ill‐informed and lacking effective evidence based support. There is a particular dearth of evidence relating to women with T1DM. Conclusions: This review provides evidence that menopause has a negative influence upon quality of life for many women with diabetes. The impacts span managing diabetes and menopausal symptoms and seeking and receiving support. A hypothesised bidirectional relationship between diabetes and menopause may exist: whereby progression of one may be influenced by the other also resulting in a lower quality of life. While high‐level evidence on this complex inter‐relationship remains limited, particularly in T1DM populations, it suggests significant unmet need for those experiencing diabetes and menopause together.
- 25 May 2025
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 20 (6) , 2013-2018
One Size Does Not Fit All: The Need for Sex-Specific Precision Medicine in Diabetes Technology
Incorporating sex-specific factors in diabetes research and treatment is essential for advancing precision medicine. There are critical gaps in understanding and applying sex-related differences. Female-specific diabetes pathophysiology manifests in three major areas: life cycle phases (including puberty, pregnancy, and menopause), lifestyle factors (such as responses to nutrition and physical activity), and insulin pharmacology. These elements significantly affect insulin sensitivity and glycemic control in women, yet are frequently underrepresented or ignored in both research and clinical practice. Greater research and clinical focus across these domains is needed to better understand and address sex-based differences in diabetes. Identifying and filling evidence gaps will support more systematic and effective care.
- 25 May 2025
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 20 (6) , 2013-2018
One Size Does Not Fit All: The Need for Sex-Specific Precision Medicine in Diabetes Technology
Incorporating sex-specific factors in diabetes research and treatment is essential for advancing precision medicine. There are critical gaps in understanding and applying sex-related differences. Female-specific diabetes pathophysiology manifests in three major areas: life cycle phases (including puberty, pregnancy, and menopause), lifestyle factors (such as responses to nutrition and physical activity), and insulin pharmacology. These elements significantly affect insulin sensitivity and glycemic control in women, yet are frequently underrepresented or ignored in both research and clinical practice. Greater research and clinical focus across these domains is needed to better understand and address sex-based differences in diabetes. Identifying and filling evidence gaps will support more systematic and effective care.
- Open Access
- 1 November 2022
- Published by MDPI AG in Engineering Proceedings
- Vol. 27 (1) , 20
On the Use of Deep Learning Decompositions and Physiological Measurements for the Prediction of Preterm Pregnancies in a Cohort of Patients in Active Labor
Preterm pregnancies are one of the leading causes of morbidity and mortality amongst children under the age of five. This is a global issue and has been identified as an area requiring active research. The emphasis now is to identify and develop methods of predicting the likelihood of preterm birth. This paper uses physiological data from a group of patients in active labor. The dataset contains information about fetal heart rate (FHR) and maternal heart rate (MHR) for all patients and electrohysterogram (EHG) recordings for the measurement of uterine contractions. For the physiological data analysis and associated signal processing, we utilize deep wavelet scattering (DWS). This is an unsupervised decomposition and feature extraction method combining characteristics from deep learning convolutions, as well as the classical wavelet transform, to observe and investigate the extent to which active preterm labor can be accurately identified from an acquired physiological signal, the results of which were compared with the metaheuristic linear series decomposition learner (LSDL). Additional machine learning algorithms are tested on the acquired physiological data to allow for the identification of optimal model architecture for this specific physiological data.
- 1 November 2022
- Published by MDPI AG in Engineering Proceedings
- Vol. 27 (1) , 20
Open AccessOn the Use of Deep Learning Decompositions and Physiological Measurements for the Prediction of Preterm Pregnancies in a Cohort of Patients in Active Labor
Preterm pregnancies are one of the leading causes of morbidity and mortality amongst children under the age of five. This is a global issue and has been identified as an area requiring active research. The emphasis now is to identify and develop methods of predicting the likelihood of preterm birth. This paper uses physiological data from a group of patients in active labor. The dataset contains information about fetal heart rate (FHR) and maternal heart rate (MHR) for all patients and electrohysterogram (EHG) recordings for the measurement of uterine contractions. For the physiological data analysis and associated signal processing, we utilize deep wavelet scattering (DWS). This is an unsupervised decomposition and feature extraction method combining characteristics from deep learning convolutions, as well as the classical wavelet transform, to observe and investigate the extent to which active preterm labor can be accurately identified from an acquired physiological signal, the results of which were compared with the metaheuristic linear series decomposition learner (LSDL). Additional machine learning algorithms are tested on the acquired physiological data to allow for the identification of optimal model architecture for this specific physiological data.
- Open Access
- 1 November 2022
- Published by MDPI AG in Engineering Proceedings
- Vol. 27 (1) , 19
A Pilot on the Endocrine Effects of Hormonal Replacement Therapy on Menopausal T1 Diabetics Using Wearable Sensors
Menopause is an under-reported and under-researched life stage for women living with type 1 diabetes (T1D) despite its lasting approximately 20 years. Menopause is associated with metabolic dysfunction leading to weight gain, impaired insulin sensitivity, hypertension, and hypercholesterolemia, each of which diminishes longevity for women living with diabetes. Its symptoms, affecting cognition, sleep patterns, mood, cardiac and vascular health, and physical health, are known to impact glucose variability dynamics. Associated vasomotor symptoms of hot-flushes/night-sweats, mood swings, anxiety, depression, and sexual dysfunction make it difficult to differentiate between symptoms of menopause and hypoglycemia. While it is recognized that transitioning through menopause increases the potential for developing diabetes, there are no recommendations on managing glucose variability or insulin resistance for women with pre-existing diabetes. Increasingly, women using wearable glucose sensor technologies, insulin pumps, and artificial pancreas systems have self-identified increased glucose variability in the data sets provided by wearable digital health technologies. These datasets, collected in real-time from women outside of traditional research settings, would have been unimaginable 20 years ago. Women highlighting the knowledge deficit are driven to learn and share more about menopause. Their quest for clinician support about the impact of hormone replacement therapies (HRT) on glycemic variability, and the associated risk of developing additional comorbidities, further illustrates the importance of this subject. This work uses datasets from wearable sensors, contributed by women with T1D to inform an understanding of their collective perimenopause and menopause journeys. Glucose readings across a period of weeks, leading up to and immediately following the initiation of prescribed medications, have been analyzed to investigate the physiological effects of HRT on the endocrine system of this sample of menopausal T1D women. Self-management and peer support is bridging the research void, which is why there should be more research into this topic.
- 1 November 2022
- Published by MDPI AG in Engineering Proceedings
- Vol. 27 (1) , 19
Open AccessA Pilot on the Endocrine Effects of Hormonal Replacement Therapy on Menopausal T1 Diabetics Using Wearable Sensors
Menopause is an under-reported and under-researched life stage for women living with type 1 diabetes (T1D) despite its lasting approximately 20 years. Menopause is associated with metabolic dysfunction leading to weight gain, impaired insulin sensitivity, hypertension, and hypercholesterolemia, each of which diminishes longevity for women living with diabetes. Its symptoms, affecting cognition, sleep patterns, mood, cardiac and vascular health, and physical health, are known to impact glucose variability dynamics. Associated vasomotor symptoms of hot-flushes/night-sweats, mood swings, anxiety, depression, and sexual dysfunction make it difficult to differentiate between symptoms of menopause and hypoglycemia. While it is recognized that transitioning through menopause increases the potential for developing diabetes, there are no recommendations on managing glucose variability or insulin resistance for women with pre-existing diabetes. Increasingly, women using wearable glucose sensor technologies, insulin pumps, and artificial pancreas systems have self-identified increased glucose variability in the data sets provided by wearable digital health technologies. These datasets, collected in real-time from women outside of traditional research settings, would have been unimaginable 20 years ago. Women highlighting the knowledge deficit are driven to learn and share more about menopause. Their quest for clinician support about the impact of hormone replacement therapies (HRT) on glycemic variability, and the associated risk of developing additional comorbidities, further illustrates the importance of this subject. This work uses datasets from wearable sensors, contributed by women with T1D to inform an understanding of their collective perimenopause and menopause journeys. Glucose readings across a period of weeks, leading up to and immediately following the initiation of prescribed medications, have been analyzed to investigate the physiological effects of HRT on the endocrine system of this sample of menopausal T1D women. Self-management and peer support is bridging the research void, which is why there should be more research into this topic.
- Open Access
- 1 November 2021
- Published by MDPI AG in Engineering Proceedings
- Vol. 10 (1) , 60
Pregnancy Labor Prediction Using Magnetomyography Sensing and a Self-Sorting Cybernetic Model
To date, effective means of predicting pregnancy labor continues to lack. Magnetic field signals during uterine contraction have shown, in recent studies, to be a good source of information for predicting labor state with a greater accuracy compared with existing methods. The means of labor prediction methods from such signals appear to rely on a supervised learning post-processing framework whose calibration relies on an effective labelling of the training sample set. As a potential solution to this, using a reduced electrode channel from magnetomyography instrumentation, we propose a multi-stage self-sorting cybernetic model that is comprised of an ensemble of various post-processing methods, and is underpinned by an unsupervised learning framework that allows for an automated method towards learning from the trend in the data to infer labor state and imminency. Experimental results showed a comparable accuracy with those from a supervised learning method adopted in a prior study. Additionally, an architecture of how an intelligent cybernetic model can be used for labor prediction and cost saving benefits within a clinical setting is offered by this study.
- 1 November 2021
- Published by MDPI AG in Engineering Proceedings
- Vol. 10 (1) , 60
Open AccessPregnancy Labor Prediction Using Magnetomyography Sensing and a Self-Sorting Cybernetic Model
To date, effective means of predicting pregnancy labor continues to lack. Magnetic field signals during uterine contraction have shown, in recent studies, to be a good source of information for predicting labor state with a greater accuracy compared with existing methods. The means of labor prediction methods from such signals appear to rely on a supervised learning post-processing framework whose calibration relies on an effective labelling of the training sample set. As a potential solution to this, using a reduced electrode channel from magnetomyography instrumentation, we propose a multi-stage self-sorting cybernetic model that is comprised of an ensemble of various post-processing methods, and is underpinned by an unsupervised learning framework that allows for an automated method towards learning from the trend in the data to infer labor state and imminency. Experimental results showed a comparable accuracy with those from a supervised learning method adopted in a prior study. Additionally, an architecture of how an intelligent cybernetic model can be used for labor prediction and cost saving benefits within a clinical setting is offered by this study.
- Open Access
- 1 November 2021
- Published by MDPI AG in Engineering Proceedings
- Vol. 10 (1) , 20
Predictive Glucose Monitoring for People with Diabetes Using Wearable Sensors
Diabetes is a chronic non-communicable disease resulting from pancreatic inability to produce the hormone insulin, or a physiological cellular inability to use this hormone effectively. This leads to unregulated blood glucose levels, which can cause significant and often irreversible physiological damage. Current means of glucose level monitoring range from infrequent capillary blood glucose sampling to continuous interstitial fluid glucose monitoring. However, the accuracy of these methods is limited by numerous factors. A potential solution to this shortcoming involves the use of wearable sensors that record an individual’s physiological responses to a range of daily activities, which are subsequently fused and processed with machine learning (ML) algorithms to provide a prediction of an individual’s glucose level and can provide an artificial intelligence-driven glucose monitoring platform. In this paper, we conduct a comparison case study using quadratic discriminant analysis (QDA) and support vector machine (SVM) algorithms for the classification of glucose levels with data acquired from the wearable sensors of a type 1 diabetic individual. Preliminary results demonstrate predicted glucose levels with >70% accuracy, indicating potential for this approach to be used in the design of an ergonomic glucose prediction platform utilizing wearable sensors. Further work will involve the exploration of additional datasets from affordable wearables to enhance and improve the prediction power of the ML algorithms.
- 1 November 2021
- Published by MDPI AG in Engineering Proceedings
- Vol. 10 (1) , 20
Open AccessPredictive Glucose Monitoring for People with Diabetes Using Wearable Sensors
Diabetes is a chronic non-communicable disease resulting from pancreatic inability to produce the hormone insulin, or a physiological cellular inability to use this hormone effectively. This leads to unregulated blood glucose levels, which can cause significant and often irreversible physiological damage. Current means of glucose level monitoring range from infrequent capillary blood glucose sampling to continuous interstitial fluid glucose monitoring. However, the accuracy of these methods is limited by numerous factors. A potential solution to this shortcoming involves the use of wearable sensors that record an individual’s physiological responses to a range of daily activities, which are subsequently fused and processed with machine learning (ML) algorithms to provide a prediction of an individual’s glucose level and can provide an artificial intelligence-driven glucose monitoring platform. In this paper, we conduct a comparison case study using quadratic discriminant analysis (QDA) and support vector machine (SVM) algorithms for the classification of glucose levels with data acquired from the wearable sensors of a type 1 diabetic individual. Preliminary results demonstrate predicted glucose levels with >70% accuracy, indicating potential for this approach to be used in the design of an ergonomic glucose prediction platform utilizing wearable sensors. Further work will involve the exploration of additional datasets from affordable wearables to enhance and improve the prediction power of the ML algorithms.